PT2607354E - Novo processo de síntese da ivabradina e dos seus sais de acição a um ácido aceitável do ponto de vista farmacêutico - Google Patents
Novo processo de síntese da ivabradina e dos seus sais de acição a um ácido aceitável do ponto de vista farmacêutico Download PDFInfo
- Publication number
- PT2607354E PT2607354E PT121979298T PT12197929T PT2607354E PT 2607354 E PT2607354 E PT 2607354E PT 121979298 T PT121979298 T PT 121979298T PT 12197929 T PT12197929 T PT 12197929T PT 2607354 E PT2607354 E PT 2607354E
- Authority
- PT
- Portugal
- Prior art keywords
- ivabradine
- synthesis
- pharmaceutically acceptable
- addition salts
- acceptable acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1103934A FR2984320B1 (fr) | 2011-12-20 | 2011-12-20 | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2607354E true PT2607354E (pt) | 2014-08-27 |
Family
ID=47355960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT121979298T PT2607354E (pt) | 2011-12-20 | 2012-12-19 | Novo processo de síntese da ivabradina e dos seus sais de acição a um ácido aceitável do ponto de vista farmacêutico |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US8507668B2 (pt) |
| EP (1) | EP2607354B1 (pt) |
| JP (1) | JP5531084B2 (pt) |
| KR (1) | KR101479986B1 (pt) |
| CN (1) | CN103172567B (pt) |
| AR (1) | AR089325A1 (pt) |
| AU (1) | AU2012261583B2 (pt) |
| BR (1) | BR102012032562A2 (pt) |
| CA (1) | CA2798633C (pt) |
| CL (1) | CL2012003579A1 (pt) |
| CY (1) | CY1115620T1 (pt) |
| DK (1) | DK2607354T3 (pt) |
| EA (1) | EA021713B1 (pt) |
| ES (1) | ES2516290T3 (pt) |
| FR (1) | FR2984320B1 (pt) |
| GE (1) | GEP20156245B (pt) |
| HK (1) | HK1186734A1 (pt) |
| HR (1) | HRP20140839T1 (pt) |
| JO (1) | JO3083B1 (pt) |
| MA (1) | MA34868B1 (pt) |
| MD (1) | MD4275C1 (pt) |
| MX (1) | MX2012014321A (pt) |
| MY (1) | MY160928A (pt) |
| PE (1) | PE20131325A1 (pt) |
| PL (1) | PL2607354T3 (pt) |
| PT (1) | PT2607354E (pt) |
| RS (1) | RS53470B (pt) |
| SA (1) | SA112340106B1 (pt) |
| SG (1) | SG191498A1 (pt) |
| SI (1) | SI2607354T1 (pt) |
| TW (1) | TWI440628B (pt) |
| UA (1) | UA111156C2 (pt) |
| UY (1) | UY34508A (pt) |
| WO (1) | WO2013093333A1 (pt) |
| ZA (1) | ZA201209369B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2988720B1 (fr) * | 2012-03-27 | 2014-03-14 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2681862B1 (fr) * | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
| FR2868776B1 (fr) * | 2004-04-13 | 2008-04-18 | Servier Lab | Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2868777B1 (fr) * | 2004-04-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2868775B1 (fr) * | 2004-04-13 | 2008-04-11 | Servier Lab | Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2870537A1 (fr) * | 2004-05-19 | 2005-11-25 | Servier Lab | Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| RU2473544C2 (ru) * | 2007-05-30 | 2013-01-27 | Инд-Свифт Лабораториз Лимитед | Способ получения ивабрадина гидрохлорида и его полиморфных модификаций |
| FR2920773B1 (fr) * | 2007-09-11 | 2009-10-23 | Servier Lab | Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2932800B1 (fr) * | 2008-06-20 | 2015-02-20 | Servier Lab | Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2935381B1 (fr) * | 2008-08-29 | 2010-12-17 | Servier Lab | Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine |
| FR2940287B1 (fr) * | 2008-12-24 | 2010-12-24 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable. |
| FR2941695B1 (fr) * | 2009-02-04 | 2011-02-18 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| AU2010216150B2 (en) * | 2009-02-17 | 2015-05-14 | Mallinckrodt Llc | Process for the reductive alkylation of normorphinans |
| FR2943668B1 (fr) * | 2009-03-31 | 2011-05-06 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable. |
-
2011
- 2011-12-20 FR FR1103934A patent/FR2984320B1/fr not_active Expired - Fee Related
-
2012
- 2012-12-04 SG SG2012089041A patent/SG191498A1/en unknown
- 2012-12-05 PE PE2012002275A patent/PE20131325A1/es active IP Right Grant
- 2012-12-06 JO JOP/2012/0370A patent/JO3083B1/ar active
- 2012-12-07 MX MX2012014321A patent/MX2012014321A/es active IP Right Grant
- 2012-12-07 MY MYPI2012701116A patent/MY160928A/en unknown
- 2012-12-07 AU AU2012261583A patent/AU2012261583B2/en not_active Ceased
- 2012-12-11 CA CA2798633A patent/CA2798633C/fr not_active Expired - Fee Related
- 2012-12-11 ZA ZA2012/09369A patent/ZA201209369B/en unknown
- 2012-12-11 UY UY0001034508A patent/UY34508A/es unknown
- 2012-12-14 US US13/714,950 patent/US8507668B2/en not_active Expired - Fee Related
- 2012-12-14 MD MDA20120123A patent/MD4275C1/ro not_active IP Right Cessation
- 2012-12-18 SA SA112340106A patent/SA112340106B1/ar unknown
- 2012-12-18 KR KR20120148761A patent/KR101479986B1/ko active IP Right Grant
- 2012-12-18 GE GEAP201212929A patent/GEP20156245B/en unknown
- 2012-12-18 UA UAA201214527A patent/UA111156C2/uk unknown
- 2012-12-19 BR BR102012032562-4A patent/BR102012032562A2/pt not_active Application Discontinuation
- 2012-12-19 CN CN201210554758.0A patent/CN103172567B/zh not_active Expired - Fee Related
- 2012-12-19 DK DK12197929.8T patent/DK2607354T3/da active
- 2012-12-19 MA MA35475A patent/MA34868B1/fr unknown
- 2012-12-19 PL PL12197929T patent/PL2607354T3/pl unknown
- 2012-12-19 AR ARP120104818A patent/AR089325A1/es unknown
- 2012-12-19 SI SI201230075T patent/SI2607354T1/sl unknown
- 2012-12-19 EA EA201201571A patent/EA021713B1/ru not_active IP Right Cessation
- 2012-12-19 CL CL2012003579A patent/CL2012003579A1/es unknown
- 2012-12-19 TW TW101148518A patent/TWI440628B/zh not_active IP Right Cessation
- 2012-12-19 PT PT121979298T patent/PT2607354E/pt unknown
- 2012-12-19 RS RS20140425A patent/RS53470B/en unknown
- 2012-12-19 JP JP2012276524A patent/JP5531084B2/ja active Active
- 2012-12-19 ES ES12197929.8T patent/ES2516290T3/es active Active
- 2012-12-19 EP EP12197929.8A patent/EP2607354B1/fr active Active
- 2012-12-19 WO PCT/FR2012/052982 patent/WO2013093333A1/fr active Application Filing
-
2013
- 2013-12-23 HK HK13114206.6A patent/HK1186734A1/xx not_active IP Right Cessation
-
2014
- 2014-09-04 HR HRP20140839AT patent/HRP20140839T1/hr unknown
- 2014-10-14 CY CY20141100833T patent/CY1115620T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181696T1 (hr) | Postupak za pripremu dipeptidnih derivata lizin-glutaminske kiseline | |
| PL2531286T3 (pl) | Sposób syntezy metanolu | |
| EP2740478A4 (en) | PREPARATION FOR MAINTAINED RELEASE OF IVABRADINE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | |
| ZA201105172B (en) | New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| PL2241553T3 (pl) | Sposób syntezy iwabradyny i jej soli addycyjnych z kwasem dopuszczalnym farmaceutycznie | |
| ZA201404246B (en) | Process for the preparation of(5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-1yl)-acetic acid | |
| ZA201201329B (en) | New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| SI2736909T1 (sl) | Proces za pripravo sitagliptina in njegovih farmacevtsko sprejemljivih soli | |
| ZA201207397B (en) | Process for the preparation of dexlansoprazole | |
| HK1197069A1 (en) | Methods for the synthesis and purification of deoxycholic acid | |
| HK1169827A1 (en) | Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| HK1183488A1 (en) | Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| IN2012DE00289A (pt) | ||
| HU1000565D0 (en) | Process for the preparation of pharmaceutically active compound and intermediers | |
| IL225680A0 (en) | Process for preparing 3-(6-amino-pyridin-3-yl)2-acrylic acid derivatives | |
| HK1186733A1 (zh) | 合成伊伐布雷定以及其與可藥用酸的加成鹽的新方法 | |
| PT2607354E (pt) | Novo processo de síntese da ivabradina e dos seus sais de acição a um ácido aceitável do ponto de vista farmacêutico | |
| HK1189892A1 (zh) | 合成伊伐布雷定以及其可藥用酸加成鹽的新方法 | |
| PL2739610T3 (pl) | Sposób wytwarzania iwabradyny i związków pośrednich w jej syntezie | |
| EP2828251A4 (en) | IMPROVED METHOD FOR THE PRODUCTION OF SUNITINIB AND ITS ACID ADDITIONAL SALTS THEREOF | |
| PL396871A1 (pl) | Kwas naftaleno-1,4-difosfonowy, sposób wytwarzania kwasu naftaleno-1,4-difosfonowego i zastosowanie kwasu naftaleno-1,4-difosfonowego | |
| PL393253A1 (pl) | Nowe pochodne kwasu betulinowego i sposób ich otrzymywania | |
| ZA201107792B (en) | Process for the preparation of highly pure duloxetine hydrochloride | |
| ZA200905507B (en) | Improved process for the preparation of phenethylamine derivatives |